Medical Oncology » Physicians

• Language(s): English, Punjabi, Hindi

• College: University of Bombay
• Medical School: University of Bombay
• Internship: Henry Ford Hospital
• Residency: Henry Ford Hospital
• Fellowship: Henry Ford Hospital
• Board Certification: American Board of Internal Medicine, Hematology, Medical Oncology, Internal Medicine

Dr. Parmjeet Kumar Banghar specializes in hematology, medical oncology and internal medicine.

Dr. Banghar joined Arizona Center for Cancer Care in 2008 when his team at Arizona Center for Hematology and Oncology partnered with the practice. He earned his Bachelor of Medicine and Bachelor of Surgery degrees from the Seth G.S. Medical College at the University of Bombay in India, as well as his medical degree. Dr. Banghar would travel to the United States for his residency in internal medicine at the Henry Ford Hospital in Detroit, followed by his fellowship, where he would eventually serve as chief fellow.

Currently, Dr. Banghar is a member of the American Society of Clinical Oncology and American Society of Hematology.

He has participated in a research study involving cerebrovascular diseases and been published in several journals, including Leukemia Research and the Indian Journal of Medical Sciences. He has presented on a number of topics, including sonographic evaluation of the spleen in sickle cell syndromes, lennox gastaut syndrome and sweet syndrome in a patient with acute myeloid leukemia.

• Language(s): English

• College: University of Arizona
• Medical School: University of Nebraska College of Medicine
• Internship: University of Arizona
• Residency: University of Arizona
• Fellowship: Arizona Cancer Center Hematology/Oncology
• Board Certification: American Board of Internal Medicine, Hematology, Medical Oncology, Internal Medicine

Dr. Andrew J. Buresh specializes in medical oncology, hematology and internal medicine. He is interested in all aspects of clinical oncology and hematology, with a particular interest in
gastrointestinal, breast, lung, and prostate cancer, as well as myelodysplasia, coagulation disorders, lymphoma, and myeloma.

Dr. Buresh joined Arizona Center for Cancer Care in 2013 when Desert Springs Cancer Care Center, which he founded, partnered with the practice. He earned Bachelor of Arts degrees in Chemistry and Latin, respectively, from the University of Arizona, where he was named outstanding graduating senior in the College of Humanities. Dr. Buresh attended medical school at the University of Nebraska College of Medicine and completed his fellowship at the Arizona Cancer Center in Tucson, where he would eventually serve as chief fellow and participate in research in the field of myelodysplasia.

Dr. Buresh is a member of the American Society of Clinical Oncology, American Society of Hematology and Arizona State Physicians Association.

Dr. Buresh is a multi-year “Top Doc” honoree by Phoenix Magazine, and was chosen for the cover of the annual ranking magazine in 2013. He was also honored by the Phoenix Business Journal as among its “40 Top Business Leaders under Age 40.”

Dr. Buresh and his wife are blessed to be the proud parents of three beautiful children. When not caring for patients, Dr. Buresh enjoys spending his time with family, exercising, reading, playing basketball, golf, guitar, and coaching youth sports. He speaks basic medical Spanish.

• Languages: English and Korean
• College: Johns Hopkins University
• Medical School: Ross University School of Medicine
• Residency: Drexel University/Hahnemann University Hospital
• Fellowship: Drexel University/Hahnemann University Hospital
• Board Certifications: Internal Medicine, Medical Oncology

Dr. David Cho specializes in Hematology and Medical Oncology. He believes in a comprehensive approach to cancer care, not just to treat patients but also improve survivorship and quality of life. He also has experience in treating a wide spectrum of benign and malignant hematologic conditions.

Dr. Cho received a Bachelor’s of Arts and Sciences from the Johns Hopkins University. After college, he worked as a research fellow at the National Institutes of Health. He attended Ross University School of Medicine, graduating with Highest Honors. Dr. Cho completed both his Internal Medicine residency and Hematology/Oncology fellowship at Drexel University/Hahnemann University Hospital in Philadelphia, PA.

Throughout his academic career, Dr. Cho has had an interest in research. His work has been published and presented at local and national events. Most recently, his study comparing chemotherapy regimens for stem cell transplantation in multiple myeloma patients, was presented at the 57th American Society of Hematology Annual Meeting and Exhibition.

Dr. Cho is board certified in Internal Medicine and Oncology. He is board eligible in Hematology. He is a member of the American Society of Clinical Oncology and American Society of Hematology. In his free time, Dr. Cho enjoys spending time with his family and traveling.

• Language(s): English, French

• College: Seton Hall University
• Graduate School: A.T. Still University of Health Sciences
• Medical School: Lake Erie College of Osteopathic Medicine
• Internship: Drexel University College of Medicine/Hahnemann University Hospital
• Residency: Drexel University College of Medicine/Hahnemann University Hospital
• Fellowship: West Virginia University School of Medicine
• Board Certification: American Osteopathic Board of Internal Medicine: Medical Oncology, Internal Medicine

Dr. Brendan Curley specializes in Medical Oncology, Hematology and Internal Medicine. His clinical interests include breast, colon, lung and prostate cancer, and has strong experience and interest in hematologic malignancies. He also enjoys caring for and treating all aspects of benign hematology. He has strong research background in improving patient’s quality of care and patient understanding of their diagnosis and treatment.

Dr. Curley joined Arizona Center for Cancer Care in 2014. He received his Bachelor of Science degree in Biology from Seton Hall University in New Jersey. He completed medical school at Lake Erie College of Osteopathic Medicine in Erie, Pennsylvania. Dr. Curley completed both his internship and residency in Internal Medicine at Drexel University College of Medicine/Hahnemann University Hospital, in Philadelphia, PA. He completed his fellowship in Hematology/Oncology at West Virginia University School of Medicine, where he served as chief fellow his final year.

Dr. Curley has been published in several medical journals, including The Journal of Oncology Practice, Clinical Lymphoma, Myeloma, & Leukemia, and The American Journal of Medical Sciences. He authored the breast cancer chapter in fourth edition of The Bethesda Handbook of Clinical Oncology. Dr. Curley is a multi-year winner of the American Society of Clinical Oncology Merit Award awarded to fellows with highly regarded research. During fellowship, he was twice named fellow of the year and was recognized by the Department of Medicine for his academic excellence and research achievements.

Dr. Curley is a member of the American Society of Clinical Oncology, American Society of Hematology, and American Osteopathic Association. He enjoys spending time with his wife, two daughters, and English Bulldog.

• Language(s): English, Punjabi, Hindi, Spanish

• Medical School: Dayanand Medical College
• Internship: Mount Sinai School of Medicine
• Residency: Mount Sinai School of Medicine
• Fellowship: Drexel University
• Board Certifications: American Board of Internal Medicine: Hematology, Medical Oncology, Internal Medicine

Dr. Dhillon is fellowship trained in Hematology and Medical Oncology. He received Hematology & Oncology fellowship training at Drexel University College of Medicine, Philadelphia. During the final year of his training, he served as Chief Fellow, and Instructor for Drexel University medical students. Dr. Dhillon is board-certified in Medical Oncology, Hematology and Internal Medicine.

Dr. Dhillon received his medical degree from Dayanand Medical College, Ludhiana, India. Subsequently, he completed internship and residency training in Internal Medicine at Mount Sinai School of Medicine, St. Joseph’s Regional Medical Center program in Paterson, NJ. After finishing residency, and prior to starting fellowship training, he worked as Clinical Instructor in Medicine at Thomas Jefferson University in Philadelphia.

Dr. Dhillon’s clinical interests include a broad spectrum of disorders including solid tumors, hematologic malignancies, and benign hematologic disorders. His special interests include myeloma, lymphoma, breast cancer, gastrointestinal malignancies, prostate cancer, and lung cancer. Dr. Dhillon also specializes in treatment of disorders of blood cells, bleeding and coagulation disorders.

Dr. Dhillon has participated in a number of research projects. He has presented his work at national meetings, and published in journals, including the New England Journal of Medicine.

Dr. Dhillon is an advocate of collaborative and patient-centered cancer care that delivers effective treatment while maintaining quality of life.

Dr. Dhillon lives in Chandler, AZ. He enjoys spending time with family, exercising, traveling, writing, and watching sports.

• Language(s): English

• College: University of Colorado
• Medical School: Midwestern University
• Internship: Rush University Medical Center
• Residency: Rush University Medical Center
• Fellowship: Baylor University Medical Center
• Board Certification: American Board of Internal Medicine, Medical Oncology, Internal Medicine

Dr. Justin Goldfarb specializes in medical oncology, internal medicine and hematology.

Growing up in suburban Detroit, Dr. Goldfarb followed his true passion to become a hematologist and medical oncologist. A published author on topics including lymphoma and breast cancer, he is double board-certified in medical oncology and internal medicine, and fellowship-trained in hematologic disorders and solid tumors.

Dr. Goldfarb earned a Bachelor’s degree from the University of Colorado at Boulder and holds a medical degree from Midwestern University in Chicago. He completed an internal medicine residency at Rush University Medical Center in Chicago, followed by a medical oncology fellowship at Baylor University Medical Center in Dallas. With academic appointments at Pritzker School of Medicine at the University of Chicago and Midwestern University, Dr. Goldfarb thoroughly enjoys teaching and mentoring medical students.

• Language(s): English

• College: City College of New York
• Medical School: State University of New York at Buffalo
• Internship: University of Chicago Hospital and Clinics
• Residency: University of Chicago Hospital and Clinics
• Fellowship: Memorial Sloan-Kettering Cancer Center
• Board Certification: American Board of Internal Medicine, Medical Oncology, Internal Medicine

Dr. Michael S. Gordon specializes in medical oncology and hematology, and his principle interests have been in the development of new cancer therapies with a focus on targeted therapies as well as drugs that affect angiogenesis (tumor blood vessel supply). His disease focuses include kidney cancer, melanoma, prostate cancer, gastrointestinal stromal tumor (GIST) and ovarian cancer. In 2014, Dr. Gordon was named medical director for the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute.

Dr. Gordon joined Arizona Center for Cancer Care in 2013 when his team at Pinnacle Oncology Hematology partnered with them. He first came to Arizona to become the associate dean for research for the Phoenix campus of the University of Arizona College of Medicine and subsequently founded the Arizona Cancer Center’s Drug Development Program in Scottsdale. Dr. Gordon led the Arizona Cancer Center’s activities in the greater-Phoenix area until November 2005 when the Drug Development Program was converted to Pinnacle Oncology Hematology as a free-standing research practice. Pinnacle Oncology joined Arizona Center for Cancer Care in 2013. Currently, Dr. Gordon also serves as an associate professor of clinical medicine at the University of Arizona College of Medicine.

Dr. Gordon received his Bachelor of Science degree in Biomedical Sciences from the Sophie Davis School for Biomedical Education at the City College of New York and his Medical degree from the State University of New York at Buffalo School of Medicine. Following his graduation from medical school, Dr. Gordon performed his internship and residency in Internal Medicine at the University of Chicago Hospitals and Clinics. After completing his fellowship in Hematology/Oncology at Memorial Sloan-Kettering Cancer Center in 1991, he accepted a position at the Indiana University School of Medicine as a faculty member in the Section of Hematology/Oncology. During nine years on the faculty at Indiana University, Dr. Gordon played integral roles in the development of the Indiana University Cancer Center’s Biologics and Developmental Therapeutics Program, the Leukemia Program, Clinical Research Office, and the Scientific Review Committee.

Dr. Gordon is a member of the American College of Physicians, American Society of Clinical Oncology, International Society of Experimental Hematology, American Society of Hematology, American Association for Cancer Research and New York Academy of Science. He has been awarded the American Cancer Society’s Clinical Oncology Career Development Award and has served as co-editor of Yearbook of Oncology.